Asia Pacific Cell and Gene Therapy Manufacturing QC Market Size & Outlook, 2025-2028
Asia Pacific Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the Asia Pacific Cell and Gene Therapy Manufacturing QC Market was valued at USD 754.58 million in 2024 and is projected to reach USD 1913.16 million by 2028, expanding at a CAGR of 26.3% during the forecast period. This region's growth is primarily fueled by increased demand in industries such as pharmaceuticals, biotechnology and healthcare. Key drivers include advancements in technology and an increase in the occurrence of genetic disorders, which require cell and gene therapy. Emerging trends such as more sustainable, low-carbon production methods and digital solutions for quality control are creating new opportunities in the market. As home to some of the world's fastest-growing economies, the Asia-Pacific region is strategically positioning itself as a global hub for cell and gene therapy manufacturing and quality control.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market Highlights
- In 2024, Cell Therapy emerged as the dominant Therapy Type based on market size.
- Gene Therapy is projected to register the fastest growth, positioning it as the most attractive Therapy Type segment over the forecast horizon.
- Asia Pacific held 33.75% share of the global cell and gene therapy manufacturing qc market size in 2024.
- United States is expected to remain the largest contributor to the global market by 2028.
- By 2028, India is anticipated to record the highest growth in Asia Pacific, with the market size expected to reach USD 58503 Million.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2028 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2028 |
| Market Size In 2024 | USD 754.58 Million |
| Market Size In 2028 | USD 1913.16 Million |
| Largest segment | Cell Therapy |
| Fastest segment | Gene Therapy |
| Units | Revenue in USD Million |
| CAGR | 26.3% (2025-2028) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Asia Pacific Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Country |
|
| Therapy Type |
|
| Cell Therapy |
|
| CAR-T |
|
| Gene Therapy |
|
| Viral |
|
| Scale |
|
| Mode |
|
| Workflow |
|
| Process |
|
| End User |
|
| Pharmaceutical Companies |
|
| Biopharmaceutical / Biotechnological Companies |
|
| Contract Manufacturing Organizations |
|
| Technology Type |
|
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Country 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Asia Pacific Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
